Thomas David Hull III Sells 1,844 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,844 shares of the firm’s stock in a transaction on Monday, April 14th. The shares were sold at an average price of $32.44, for a total value of $59,819.36. Following the transaction, the chief executive officer now owns 36,072 shares in the company, valued at approximately $1,170,175.68. This represents a 4.86 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Monday, March 24th, Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.63, for a total transaction of $136,890.00.
• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The shares were sold at an average price of $48.53, for a total transaction of $10,336.89.

Kewaunee Scientific Trading Up 6.0 %

KEQU opened at $34.09 on Wednesday. Kewaunee Scientific Co. has a 12 month low of $30.82 and a 12 month high of $71.33. The stock has a fifty day moving average price of $48.40 and a 200-day moving average price of $47.35. The firm has a market cap of $97.33 million, a price-to-earnings ratio of 5.40 and a beta of 0.59. The company has a current ratio of 2.64, a quick ratio of 2.13 and a debt-to-equity ratio of 0.45.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The business had revenue of $67.17 million during the quarter.

Institutional Investors Weigh In On Kewaunee Scientific

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of America Corp DE increased its position in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after purchasing an additional 443 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Kewaunee Scientific by 18,000.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after buying an additional 900 shares during the last quarter. IFP Advisors Inc acquired a new position in Kewaunee Scientific during the 4th quarter valued at about $36,000. Morgan Dempsey Capital Management LLC purchased a new stake in Kewaunee Scientific in the fourth quarter valued at about $106,000. Finally, Barclays PLC purchased a new stake in shares of Kewaunee Scientific during the third quarter worth about $121,000. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.